These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31343304)
21. The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition. Wixner J; Westermark P; Ihse E; Pilebro B; Lundgren HE; Anan I Amyloid; 2019; 26(sup1):39-40. PubMed ID: 31343354 [No Abstract] [Full Text] [Related]
22. Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54. Imasawa M; Toda Y; Sakurada Y; Imai M; Iijima H Acta Ophthalmol Scand; 2004 Oct; 82(5):635-7. PubMed ID: 15453875 [No Abstract] [Full Text] [Related]
23. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis. Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881 [TBL] [Abstract][Full Text] [Related]
24. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review. Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824 [No Abstract] [Full Text] [Related]
25. Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis. Miller M; Pal A; Albusairi W; Joo H; Pappas B; Haque Tuhin MT; Liang D; Jampala R; Liu F; Khan J; Faaij M; Park M; Chan W; Graef I; Zamboni R; Kumar N; Fox J; Sinha U; Alhamadsheh M J Med Chem; 2018 Sep; 61(17):7862-7876. PubMed ID: 30133284 [TBL] [Abstract][Full Text] [Related]
26. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation. Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593 [TBL] [Abstract][Full Text] [Related]
27. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant. Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893 [No Abstract] [Full Text] [Related]
37. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]
38. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only. Ran LX; Zheng ZY; Xie B; Nie XM; Chen XW; Su G; Cai SJ Exp Eye Res; 2018 Apr; 169():13-19. PubMed ID: 29360446 [TBL] [Abstract][Full Text] [Related]
39. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis. Rosenblum H; Castano A; Alvarez J; Goldsmith J; Helmke S; Maurer MS Circ Heart Fail; 2018 Apr; 11(4):e004769. PubMed ID: 29615436 [TBL] [Abstract][Full Text] [Related]
40. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Liepnieks JJ; Wilson DL; Benson MD Amyloid; 2006 Sep; 13(3):170-7. PubMed ID: 17062384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]